Asthma & Nasal Transcriptomics: Author Reply
- Transcriptomic profiles previously identified in adults with asthma have been successfully replicated in youth, according to a new study.
- earlier studies by Choy et al.and Diver et al., using bronchial epithelial samples, pinpointed three distinct asthma profiles: T2HIGH, T17HIGH, and T2LOW/T17LOW.
- Further research is needed to explore the clinical implications of these distinct asthma profiles and to develop targeted therapies based on individual immune response signatures.
Groundbreaking research reveals that distinct asthma profiles, previously observed in adults, are consistently replicated in youth, solidifying the understanding of the immune response role.This study, analyzing nasal epithelial samples, confirms the T2HIGH, T17HIGH, and T2LOW/T17LOW asthma profiles, mirroring findings in older populations. The research focuses on eight signature genes linked to T2 and T17 immune responses, offering crucial insights into asthma. These findings underscore the potential for targeted therapies based on individual immune signatures. News Directory 3 keeps you informed.What clinical implications will these profiles reveal? Discover what’s next in asthma research.
Asthma Profiles Replicated in Youth: Understanding the Immune Response Role
Transcriptomic profiles previously identified in adults with asthma have been successfully replicated in youth, according to a new study. The research focused on the differential expression of eight signature genes linked to T2 and T17 immune responses, key factors in understanding the asthma role.
earlier studies by Choy et al.and Diver et al., using bronchial epithelial samples, pinpointed three distinct asthma profiles: T2HIGH, T17HIGH, and T2LOW/T17LOW. The latest research, analyzing nasal epithelial samples from young asthma patients, confirms these same three transcriptomic profiles, furthering our understanding of T2 immune responses and T17 immune responses in different age groups.
What’s next
Further research is needed to explore the clinical implications of these distinct asthma profiles and to develop targeted therapies based on individual immune response signatures.